Ingmar Hoerr
Chairman of the Executive Board / Chief Executive
Health care
CureVac
Germany
Biography
Ingmar Hoerr founded biopharmaceutical company CureVac in 2000 together with Florian von der Mülbe and other colleagues in Tübingen. His entrepreneurship was motivated by a surprising discovery during his doctoral research under Professor Günther Jung and Professor Hans-Georg Rammensee in the Department of Biology at the University of Tübingen. Experiments conducted for this research showed that the mRNA molecule class is capable of generating a strong specific immune response, contrary to what had previously been believed. From this key discovery, Ingmar Hoerr and Florian von der Mülbe built up a company that is now a global leader in the research and development of mRNA-based drugs. Ingmar Hoerr received his PhD from the University of Tübingen and his MBA from Donau University, Krems, Austria.
Research Interest
Biopharmaceutical, immune response
